Holen Sie sich die Stockscreener-App
0.1048
0.00%
0.00
Schlusskurs vom Vortag:
$0.1048
Offen:
$0.1
24-Stunden-Volumen:
55,377
Relative Volume:
33.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.29M
KGV:
-0.00308
EPS:
-34
Netto-Cashflow:
$-10.77M
1W Leistung:
-12.86%
1M Leistung:
-57.01%
6M Leistung:
-93.93%
1J Leistung:
-85.81%
1-Tages-Spanne:
$0.10
$0.111
1-Wochen-Bereich:
$0.10
$0.111
52-Wochen-Spanne:
$0.10
$0.111
Paxmedica Inc Stock (PXMD) Company Profile
Vergleichen Sie PXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PXMD | 0.1048 | 0 | 0 | -18.29M | -10.77M | -34.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Paxmedica Inc Aktie (PXMD) Neueste Nachrichten
Inside The VIP Miami Beach Cannabis Dinner Hosted By Rohan Marley And Herb: Shaping Florida's Cannabis Future - Benzinga
PaxMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K - MSN
PaxMedica Secures Immediate Exercise of Warrants - AccessWire
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - Yahoo Finance
PaxMedica (NASDAQ:PXMD) Stock Price Down 4.3% - Defense World
PaxMedica (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders - Barchart
PaxMedica sees stock surge following positive Phase 2 ASD trial results By Investing.com - Investing.com India
PaxMedica (NASDAQ:PXMD) Trading Down 4.6% - Defense World
PaxMedica (NASDAQ:PXMD) Stock Price Up 3% - Defense World
PaxMedica (NASDAQ: PXMD) Shares Corporate Update, Commitment to Advancing Therapies for Neurological ... - Barchart
PaxMedica (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher - Barchart
ATI Physical Therapy Completes Transaction Support Agreement to Increase Liquidity and Financial Flexibility - The Globe and Mail
The Globe and Mail - The Globe and Mail
PaxMedica (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments - The Globe and Mail
Closing Bell: Enablence Technologies Inc down on Thursday (ENA) - The Globe and Mail
PaxMedica files Nasdaq delisting appeal notice - MSN
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Yahoo Finance
PXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024 - InvestorPlace
IBM Introduces New Microsoft Copilot Capabilities to Fuel AI-Powered Business Transformation - The Globe and Mail
PaxMedica prepares to file NDA for use of suramin in HATTipRanks.com - TipRanks
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy - Yahoo Finance
DoorDash Earnings: What To Look For From DASH - The Globe and Mail
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast - GlobeNewswire
Urgent Action: PaxMedica (NASDAQ: PXMD) Addresses Medical Crisis in Malawi - Barchart
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - Yahoo Finance
A closer look at PaxMedica Inc (PXMD) is warranted – US Post News - US Post News
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - Yahoo Finance
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Benzinga
PaxMedica (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M - The Globe and Mail
Paxmedica Inc (PXMD) QuotePress Release - The Globe and Mail
PaxMedica Achieves Key Milestone in the Development of - GlobeNewswire
PaxMedica Releases Updated Investor Presentation OnlineTipRanks.com - TipRanks
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments - GlobeNewswire
PaxMedica Files 8-K Following Nasdaq Compliance Achievement - Yahoo Finance
PaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy Pipeline - Yahoo Finance
PaxMedica Inc. Covered in H.C. Wainwright & Co. Research Report - Yahoo Finance
PaxMedica CEO Featured in Just-Released Fireside Chat Video - Yahoo Finance
PaxMedica Closes Public Offering of Approximately $7M, Continues Pursuing ASD Pipeline - Yahoo Finance
PaxMedica Releases Fireside Chat Video with CEO Howard Weisman - Yahoo Finance
PaxMedica Closes on Public Offering Reaching Estimated $7M - Yahoo Finance
PaxMedica Announces Pricing of $7M Public Offering - Yahoo Finance
PaxMedica News of FDA Type-B Meeting Shared in Audio Broadcast - Yahoo Finance
Why Is PaxMedica (PXMD) Stock Down 40% Today? - InvestorPlace
PaxMedica progresses with PAX-101 for sleeping sickness By Investing.com - Investing.com UK
PaxMedica Hoping to Boost Patient Independence with Potential ASD Treatment - Yahoo Finance
What's Going On With PaxMedica Stock Today?PaxMedica (OTC:PXMD) - Benzinga
PaxMedica progresses on African Sleeping Sickness treatment, eyes 2024 NDA submission By Investing.com - Investing.com India
PaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell Podcast - GlobeNewswire
Healthcare Stocks Moving Wednesday: TNON, KRRO, VIRX, CYTH, ESTA, MRVI, PXMD, WRBY - InvestorsObserver
Why Is PaxMedica (PXMD) Stock Up 95% Today? - InvestorPlace
Finanzdaten der Paxmedica Inc-Aktie (PXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
Kapitalisierung:
|
Volumen (24h):